Single-nucleotide polymorphism in PNPLA3 (C>G, p. I148M) modifies NAFLD progression, is associated with the severity of steatohepatitis, severe fibrosis, and confers with an increased risk of developing HCC [31,32,33]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.